OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex proteins. Improving these processes involves adjusting various parameters, including cell line development, media composition, and bioreactor conditions. A key goal is to maximize antibody titer while minimizing production costs